Home›Search›CNS and Neurological Disorders - Drug Targets

CNS and Neurological Disorders - Drug Targets

Bentham Science Publishers · United Arab Emirates · Est. 1969

ISSN1871-5273eISSN1996-3181

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q2+18

Total43

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View on Clarivate Master Journal List ↗

SJR Score

0.71

H-Index

SNIP

0.603

Total Works

2,224

Total Citations

54,871

2yr Mean Citedness

1.99

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on the development and investigation of therapeutic targets and drug discovery for neurological and central nervous system disorders. It covers a range of conditions including epilepsy, cognitive dysfunction associated with COVID-19, postpartum depression, multiple sclerosis, neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease, as well as autism spectrum disorder, migraines, and gliomas. The journal explores various therapeutic strategies, including pharmacological interventions, nanotechnology-based drug delivery, modulation of molecular pathways (e.g., apoptotic, inflammatory, oxidative stress), and the role of the gut-brain axis and microbiota in neurological health.

AI-summarised from recent articles · verify on the publisher page

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 50% in field

General Information

Country / RegionUnited Arab Emirates

Primary LanguageEnglish

1st Year Published1969

Annual Volume~ 79 articles / year

StatusActive (last: 2026)

Total Publications2,224

Publisher OrgBentham Science Publishers

Region🌍 Global South

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/12 · 42%

✅

Do you know the journal / publisher?

Bentham Science Publishers

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

1871-5273 / 1996-3181

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q2

PharmacologyQ2

Neuroscience (miscellaneous)Q3

Subject Classification

Web of Science Categories

NeurosciencesPharmacology & Pharmacy

Scopus Categories

Neuroscience (miscellaneous)PharmacologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Alzheimer's disease research and treatmentsTryptophan and brain disordersCholinesterase and Neurodegenerative DiseasesNeuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology ResearchDiverse Scientific and Economic Studies14-3-3 protein interactionsNeurological Disorders and TreatmentsNeurological Disease Mechanisms and Treatments